* Hyperfine Inc HYPR.OQ reported a quarterly adjusted loss
of 14
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of -17
cents. The mean expectation of three analysts for the quarter
was for a loss of 15 cents per share. Wall Street expected
results to range from -16 cents to -14 cents per share.
* Revenue rose 54.5% to $3.30 million from a year ago;
analysts
expected $3.05 million.
* Hyperfine Inc's reported EPS for the quarter was a loss
of 14
cents.
* The company reported a quarterly loss of $9.85 million.
* Hyperfine Inc shares had fallen by 21.0% this quarter and
lost 29.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 2.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"
Wall Street's median 12-month price target for Hyperfine Inc is
$1.30
This summary was machine generated from LSEG data May 13 at
10:09 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 -0.15 -0.14 Beat
Dec. 31 2023 -0.18 -0.15 Beat
Sep. 30 2023 -0.16 -0.15 Beat
Jun. 30 2023 -0.16 -0.15 Beat